Sign up to save your podcasts
Or
Share Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Practical Perspectives: Optimizing the Role of BTK Inhibitors in the Management of Mantle Cell Lymphoma
Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Michael Wang from the University of Texas MD Anderson Cancer Center in Houston discuss the current role of Bruton tyrosine kinase inhibitors for the management of newly diagnosed and relapsed/refractory mantle cell lymphoma.
View all episodes
By Dr. Neil Love
4.4
6969 ratings
Dr Tycel Phillips from the City of Hope Comprehensive Cancer Center in Duarte, California, and Dr Michael Wang from the University of Texas MD Anderson Cancer Center in Houston discuss the current role of Bruton tyrosine kinase inhibitors for the management of newly diagnosed and relapsed/refractory mantle cell lymphoma.
More shows like Hematologic Oncology Update
View all
JAMA Editors' Summary
130 Listeners
Gastrointestinal Cancer Update
17 Listeners
Lung Cancer Update
32 Listeners
Prostate Cancer Update
15 Listeners
Breast Cancer Update
66 Listeners
Gynecologic Oncology Update
11 Listeners
Dermatologic Oncology Update
0 Listeners
NEJM This Week
324 Listeners
Research To Practice | Oncology Videos
113 Listeners
The Hematologist
26 Listeners
JAMA Clinical Reviews
492 Listeners
Annals On Call Podcast
186 Listeners
Blood Podcast
51 Listeners
Oncology Today with Dr Neil Love
52 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
169 Listeners
Blood Cancer Talks
48 Listeners